ABSTRACT The innate immune system is considered to have no immune memory. However, lately there has been as shift in paradigm. Cells of the innate immune system, and especially monocytes and macrophages, are capable of building a nonspecific memory, resulting in either better or worse responses to secondary stimulations/infections, as a result of epigenetic changes. This review gives a general overview of the at-the-moment available data.
MACROPHAGES ARE CRUCIAL FOR BOTH INNATE AND ADAPTIVE IMMUNE RESPONSES
Macrophages are a central component of antimicrobial host defense, described as being crucial for both innate immune mechanisms and adaptive immunity (1) . The dichotomy between the immediate antimicrobial responses seen as nonspecific and the relatively late-onset specific T-and B-cell responses has driven our understanding of host defense for more than half a century. Innate immunity reacts instantly upon an encounter with a pathogen but has been viewed as nonspecific and incapable of building immunological memory. In contrast, adaptive immune responses can specifically recognize pathogenic microorganisms and build memory capable of protection against reinfection. Macrophages are involved in both of these responses: on the one hand, macrophages have the capacity to phagocytose and kill microorganisms in a nonspecific fashion, as well as to release proinflammatory mediators that drive inflammation; but on the other hand, they can also present antigens and initiate and modulate the specific T-cell responses through expression of costimulatory molecules and specific cytokines (2) .
The last decade has dramatically changed the dogma of innate immunity being nonspecific, through the discovery of pattern recognition receptors (PRRs) such as the Toll-like receptors (TLRs), C-type lectin receptors, NOD-like receptors, and retinoic acid-inducible gene 1 protein (RIG-I)-like receptors. These receptors are expressed either on the surface of macrophages (and other immune cells) or intracellularly to allow specific recognition of conserved structures of different classes of microorganisms (3) . PRRs thus allow semispecific recognition of different types of microorganisms, though not individual microbial species. The widespread concept that innate immunity in general, and macrophages in particular, cannot adapt to a previous encounter with a pathogen and is incapable of building the memory of a previous infection has, however, not been contested until recently.
MACROPHAGE PRIMING, ACTIVATION, AND TOLERANCE AS ADAPTIVE RESPONSES
Since the late 1960s, it has been known that following exposure to microbes or to microbial components, mononuclear phagocytes show increased effector functions as revealed by their augmented microbicidal and tumoricidal activity (4) (5) (6) (Fig. 1 ). An unbiased survey of immunological literature reveals important clues that innate immunity is able to display adaptive features and that these mechanisms can offer protection against reinfection, independently of the classic adaptive immune memory (7, 8) . The adaptive characteristics of innate immunity, also called "trained immunity" (8) , are manifested as protection against reinfection by the same or different pathogens in organisms lacking adaptive immune responses, such as plants (9) , invertebrates (10, 11) , or mammals lacking functional T and B cells (12) (13) (14) (Table 1 ). Classic activation of macrophages requires hours, and the enhanced effector functions are transient. It was subsequently discovered that coexposure to selected cytokines (the prototype of which is gamma interferon [IFN-γ]) resulted in a dramatic increase in the responsiveness of macrophages to microbial moieties (5, 15) (Fig. 1 (17) . The discovery of alternative forms of macrophage activation, originally by IL-4 (18), has opened a new perspective on the plasticity of macrophages and their activation states (19) . Moreover, transcriptional profiling (see, e.g., reference 20) has revealed the complexity of gene regulation during "activation" and paved the way to the dissection of underlying mechanisms (19, 21) .
Deactivation can also occur as a consequence of microbial encounters (Fig. 1) . Microbial signals (e.g., LPS) under appropriate conditions can result in innate immune tolerance, i.e., in hyporesponsiveness to a subsequent challenge at the macrophage and organism level. The immunosuppressive phenotype observed in late sepsis is likely a reflection of tolerance to LPS and/or other bacterial ligands. Tolerance is generally viewed as a defense strategy to limit inflammation-caused tissue damage (22) . The definition of "tolerance" is actually as misleading as that of "activation." Analysis of the macrophage transcriptome has revealed that LPS tolerance is in fact a manifestation of reorientation of macrophage functions. The transcriptional profile of LPS-tolerant macrophages has some similarity to that expressed by alternatively activated M2-polarized macrophages (23, 24) . Tolerant macrophages have an increased expression of IL-10, arginase-1, and the chemokines CCL17 and CCL22. Thus, what has long been viewed as endotoxin tolerance is not simple unresponsiveness: it represents an adaptive response of macrophages with reorientation to an immunoregulatory phenotype.
The interaction with microbial components not only affects, but also profoundly alters, the receptor repertoire expressed by cells of the monocyte-macrophage lineage (7, 25) . It has been shown that microbes and cytokines change the levels of Dectin-1 (dendritic cellassociated C-type lectin 1) and of the scavenger receptor MARCO (macrophage receptor with collagenous structure) and hence modify subsequent responses to their ligands (7, 25) .
In addition to changing the levels and repertoire of macrophage surface receptors, inflammatory signals also induce production of fluid-phase pattern recognition molecules (PRMs). These molecules constitute the humoral arm of innate immunity together with complement (26, 27) , and they function as ancestors of antibodies ("ante-antibodies") (28) . Myelomonocytic cells are the source of a vast range of fluid-phase PRMs. These include collectins (e.g., mannose-binding lectin), ficolins (e.g., L-, H-, and M-ficolin), and pentraxins (e.g., pentraxin 3 [PTX3]) (28) . PTX3 has served as a paradigm for the mode of action of the interplay between the cellular and the humoral arms of innate immunity (29) . This "long" pentraxin is produced in a gene expressiondependent way by mononuclear phagocytes. In addition, it is stored in granular compartments in neutrophils. PTX3 is an essential component of resistance to selected pathogens such as Aspergillus fumigatus and Pseudomonas aeruginosa. The effector mechanisms utilized by PTX3 include recognition and binding to microbial components, activation and regulation of the complement cascade, and opsonization-mediated destruction of pathogens (26, 28, 29) . In addition, PTX3 binds P-selectin and reduces neutrophil recruitment to sites of inflammation, dampening inflammation (27, 30) . Thus, PTX3 and other soluble PRMs produced by phagocytes serve as an amplification and regulatory loop in the phagocyte-mediated resistance and tissue damage. The regulation of macrophage function in the lungs provides a good example of long-term conditioning of macrophage responsiveness (31, 32) . After resolution of viral infections (influenza, respiratory syncytial virus), long-lasting lung macrophage desensitization was observed (32) 
MOLECULAR MECHANISMS DRIVING THE ADAPTIVE CHARACTERISTICS OF INNATE IMMUNITY
The importance of immune adaptation as an evolutionarily driven property of complex defense systems is underlined by the discovery of an independently developed second type of adaptive immune system in jawless vertebrates, based on variable lymphocyte receptors (34) . Complementary to these phylogenetic arguments, studies investigating the ontology of the immune system have demonstrated that TLR-induced maturation of innate immunity (as assessed by cytokine profiles) is an adaptive feature of mammalian host defense that is designed to reduce the impact and severity of subsequent infections (35, 36) .
Building on these evolutionary arguments, an overview of the rich body of research documenting adaptive traits of innate immunity in plants and invertebrates provides a first set of strong arguments for innate immune memory and the molecular mechanisms that drive it (8, 11) . Systemic acquired resistance (SAR) has been described as the central process providing protection against reinfection in plants. The study of the biochemical mechanisms mediating SAR has provided the first clues that epigenetic processes are crucial for innate immune memory (37, 38). Interestingly, epigenetic changes have been shown to be able to provide transgenerational transmission of resistance, with the acetylation of histone 3 lysine 9 (H3K9) being central in this process (39) . The epigenetic programs induced in plants during SAR represent a first clue regarding the mechanisms that induce long-term changes in the functional phenotype of innate immune cells.
How the function of macrophages is modulated by microbial stimuli is an important aspect in determining host defense. Recent studies have reported that the dose of LPS determines whether tolerance (by high LPS concentrations) or priming (by ultra-low LPS concentrations) is attained when macrophages are stimulated by activation of different signaling pathways (40) . This dual role of priming and tolerance depending on the concentration applies not only to LPS but also to other ligands (41) . Epigenetic mechanisms were shown to be central in the process of LPS tolerance (42) , and links with immunometabolism become more apparent. NAD + production is an important signal leading to activation of sirtuins (histone deacetylases), which are key regulators in the epigenetic regulation of metabolism of monocytes (43, 44) . Important new insights shed more light on epigenetic regulation during cell stimulation: several types of epigenetic modifications involving both histone methylation and acetylation are induced by LPS in a cell type-and stimulus-specific manner (45) , with the most pronounced role for H3K27 acetylation (ac) (46) . However, while most of these markers fade in time, histone methylation at H3K4 monomethylation (me1) in so-called latent enhancers remains present as an epigenetic marker of this process, conferring long-term immunological memory (45) .
The importance of histone methylation and acetylation for the epigenetic reprogramming of monocytes has been also demonstrated following exposure to β-glucans, leading to an increased response to a secondary stimulation (14, 46) (Fig. 2) . Trained innate immunity induced in vivo through epigenetic reprogramming results in protection of T/B cell-deficient Scid and Rag1 -/-mice against lethal systemic candidiasis, underlining the therapeutic potential of the adaptive characteristics induced in macrophages. An important aspect observed in these studies is the lack of specificity conferred by trained immunity, in which protection is given against not only the original microorganism but additional nonrelated microorganisms as well. This was mediated by an increased phosphorylation of the p38 mitogen-activated protein kinase pathway and epigenetic changes promoting transcription in several genes, among others, PRRs, signaling molecules, and cytokines (14) . A whole-genome mapping of histone changes induced by β-glucan showed the importance of induction of H3K27ac and to a lesser extent H3K4 trimethylation (me3). Cluster analysis of genes that were epigenetically most modified revealed an upregulation of the mTOR (mammalian target of rapamycin) pathway and cell metabolism, especially glycolysis (46) . Stimulation of monocytes with β-glucan was shown to induce the Akt/mTOR/hypoxia-inducible factor-1α (HIF1α) pathway. HIF1α is an important transcriptional regulator of metabolism, and in the β-glucan-trained monocytes it was shown to induce anaerobic glycolysis (which results in lactate production) and reduce activity of the tricarboxylic acid cycle. This shift from oxidative phosphorylation (OxPhos) to anaerobic glycolysis is known as the Warburg effect and results in fast production of ATP. It was first described in cancer cells, and later also in activated macrophages (47, 48) . Apparently, trained monocytes rely on this shift to ensure their energy requirements, thus enhancing their effector functions (49) .
To conclude, these data suggest a picture in which the innate immune system is characterized by adaptive features and can be trained to provide partial protection against infection independent of the classic T/B-cell adaptive immunity. Functional reprogramming, especially through epigenetically and metabolically mediated mechanisms, mediates these effects.
CONSEQUENCES FOR HUMAN DISEASES
What are the consequences of the capacity of innate immunity to build immunological memory? Despite the data demonstrating the role of innate immune memory in plants and invertebrates, one may speculate that in mammals the biological relevance of the adaptive characteristics of innate immunity was lost during evolution, because classic T/B-cell-dependent adaptive immunity conferred the specificity needed during reinfection. However, there are several arguments to support that trained immunity remains an important component of host defense. For example, the commensalism of certain microorganisms with the mammalian host may mirror their function in inducing nonspecific immune protection. It is tempting to hypothesize that this may be the case for Candida albicans, a very common colonizer of FIGURE 2 Macrophages play a double role in inducing immunological memory following an infectious insult: on the one hand, they initiate adaptive immune responses; and on the other hand, they undergo epigenetic reprogramming to respond with an increased array of PRR expression and inflammatory cytokine production to a secondary infection ("trained innate immunity"). MHC, major histocompatibility complex.
human skin and mucosa that strongly induces trained immunity (14) , and this has also been suggested for herpesvirus latency (50) .
In addition, inducing an adaptive response of innate immunity is likely to have important therapeutic potential. Vaccines such as Mycobacterium bovis BCG have been shown to nonspecifically protect animals against fungal and bacterial sepsis (51), and BCG can nonspecifically protect mice against influenza infection (52) . If this effect was observed in humans, this would represent an unorthodox approach to vaccination in situations in which specific vaccines are not (yet) available, such as in a global pandemic with a novel influenza virus. Indeed, nonspecific protective effects against nonmycobacterial infections have been reported both to be very quick and to last for years when children are vaccinated with live vaccines such as BCG or measles vaccine (53, 54) , and the number and strength of these epidemiologic data sets strongly advocate a sustained effort to understand trained immunity and its potential therapeutic effects. In addition, not only could children in developing countries benefit from this approach, but also children in developed countries such as Spain and Denmark seem to benefit from vaccination with live attenuated vaccines, with lower hospital admission rates and fewer cases of respiratory syncytial virus infections among vaccinated children (55) (56) (57) . Furthermore, it was very recently shown that trained immunity with BCG is dependent on autophagy. Certain single nucleotide polymorphisms in autophagy genes reduced the training capacity of BCG. Subsequently, the recurrence-free survival of bladder carcinoma patients who were treated with BCG instillations was associated with these same single nucleotide polymorphisms (58) .
The results and concepts discussed here call for monitoring of the impact of new adjuvants on innate immunity and resistance to unrelated microorganisms. The challenge for the coming years is thus to deconstruct the molecular mechanisms mediating the adaptive characteristics of macrophages and other innate immune cells, as well as to harness these protective effects in clinical practice. Inducing trained innate immunity may be advantageous in various clinical conditions, from largescale vaccination programs in settings of high infectious pressure in developing countries, to vaccination of patients lacking a functional immune system (e.g., HIV patients), to the reversal of immunoparalysis in sepsis.
In conclusion, the adaptive characteristics of innate immunity in general, and of macrophages in particular, have emerged as an important new property of innate host defense mechanisms. Its study in the coming years promises to become an area of very active immunological research, with a direct impact on our understanding of immune responses and on the design of novel immunotherapies.
